Zhejiang Dayang Biotech Group Co (003017) — Strategic Asset Allocation Index
Zhejiang Dayang Biotech Group Co (003017) has a Strategic Asset Allocation Index of 62.7% as of June 2023. Strategic assets (PP&E of CN¥631.19 Million plus long-term investments of CN¥-) total CN¥631.19 Million, measured against net assets of CN¥1.01 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 003017 equity financing ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Zhejiang Dayang Biotech Group Co Strategic Asset Allocation Index (2016–2022)
This chart shows how Zhejiang Dayang Biotech Group Co's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of June 2023, the index stands at 62.7%, representing strategic assets of CN¥631.19 Million against net assets of CN¥1.01 Billion CNY. For live market cap and overall valuation, see how much is Zhejiang Dayang Biotech Group Co worth.
Annual Strategic Asset Allocation Index for Zhejiang Dayang Biotech Group Co (2016–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Zhejiang Dayang Biotech Group Co from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Zhejiang Dayang Biotech Group Co net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 62.6% | CN¥616.17 Million | CN¥616.17 Million | CN¥- | CN¥985.05 Million | ▲ +9.3 pp |
| 2021 | 53.3% | CN¥528.02 Million | CN¥528.02 Million | CN¥- | CN¥990.71 Million | ▲ +8.0 pp |
| 2020 | 45.3% | CN¥433.57 Million | CN¥433.57 Million | CN¥- | CN¥958.13 Million | ▼ -9.8 pp |
| 2019 | 55.0% | CN¥274.17 Million | CN¥274.17 Million | CN¥- | CN¥498.09 Million | ▼ -1.2 pp |
| 2018 | 56.2% | CN¥247.65 Million | CN¥247.65 Million | CN¥- | CN¥440.62 Million | ▼ -9.5 pp |
| 2017 | 65.7% | CN¥221.81 Million | CN¥221.81 Million | CN¥- | CN¥337.71 Million | ▼ -20.9 pp |
| 2016 | 86.6% | CN¥198.55 Million | CN¥198.55 Million | CN¥- | CN¥229.35 Million | — |